Design, synthesis and in vitro activities of a series of benzimidazole/benzoxazole glycoprotein IIb/IIIa inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 3, 1996, Pages 339-344

  Xue, Chu Biao ^a   Rafalski, Maria ^a   Roderick, John ^a   Eyermann, Charles J ^a   Mousa, Shaker ^a   Olson, Richard E ^a   DeGrado, William F ^a  

^a DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; BENZIMIDAZOLE DERIVATIVE; BENZOXAZOLE DERIVATIVE; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; N2 BUTYLOXYCARBONYL N3 [2 (4 AMIDINOPHENYL) 7 BENZOXAZOL 7 YL] 2,3 DIAMINOPROPIONIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; STRUCTURE ACTIVITY RELATION; THROMBOCYTE AGGREGATION;

EID: 0030065819     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(95)00590-P     Document Type: Article

References (21)

1. (a) Plow, E. F.; Ginsberg, M. H. Prog. Hemost. Thromb. 1989, 9, 117.
2. (b) Phillips, D. R.; Charo, I. F.; Scarborough, R. M. Cell 1991, 65, 359.
3. (a) Falk, E. Circulation, 1985, 71, 699.
4. (b). Coller, B.S. New Eng. J. Med. 1990, 322, 33.
5. Gartner, T. K.; Bennett, J. S. J. Biol Chem. 1985, 260, 11891.
6. For a recent review on cyclic peptide and non-peptide RGD mimetics see: Ojima, I.; Chakravarty, S.; Dong, Q. Bioorg. Med. Chem. 1995, 3, 337.
7. Mousa, S. A.; Bozarth, J. M.; Forsythe, M. S.; Lorelli, W.; Thoolen, M.; Ramachandran, N.; Jackson, S.; DeGrado, W. F.; Reilly, T. M. Cardiology 1993, 83, 374.
8. Mousa, S. A.; Bozarth, J. M.; Forsythe, M. S.; Jackson, S.; Leamy, A. Diemer, M. M.; Kapil, R. P.; Knabb, R. M.; Mayo, M. C.; Pierce, S. K.; DeGrado, W. F.; Thoolen, M. J.; Reilly, T. M. Circulation 1994, 89, 3.
9. Jackson, S.; DeGrado, W. F.; Dwivedi, A.; Parthasarathy, A.; Higley, A.; Krywko, J.; Rockwell, A.; Markwalder, J.; Wells, R.; Wexler, R.; Mousa, S.; Harlow, R. J. Am. Chem. Soc. 1994, 116, 3220.
10. Bach, A. C.; Eyermann, C. J.; Gross, J. D.; Bower, M. J.; Harlow, R. L.; Weber, P. C.; DeGrado, W. F. J. Am. Chem. Soc. 1994, 116, 3207.
11. Terashima, M.; Ishii, M.; Kanaoka, Y. Synthesis, 1982, 484.
12. 50s of these compounds in the inhibition of platelet aggregation in vitro.
13. Zablocki, J. A.; Miyano, M.; Garland, R. B.; Pireh, D.; Schretzman, L.; Rao, S. N.; Lindmark, R. J.; Panzer-Knodle, S. G.; Nicholson, N. S.; Taite, B. B.; Salyers, A. K.; King, L. W.; Campion, J. G.; Feigen, L. P. J. Med. Chem. 1993, 36, 1811.
14. (a) Ku, T. W.; Ali, F. E.; Barton, L. S.; Bean, J. W.; Bondinell, W. E.; Burgess, J. L.; Callahan, J. F.; Calvo, R. R.; Chen, L. Eggleston, D. S.; Gleason, J. G.; Huffman, W. F.; Hwang, S. M.; Jakas, D. R.; Karash, C. B.; Keenan, R. M.; Kopple, K. D.; Miller, W. H.; Newlander, K. A.; Nichols, A.; Parker, M. F.; Peishoff, C. E.; Samanen, J. M.; Uzinskas, I.; Venslavsky, J. W. J. Am. Chem. Soc. 1993, 115, 8861-8862.
15. (b) Ali, F. E.; Bennett, D. B.; Calvo, R. R.; Elliott, J. D.; Hwang, S.-M.; Ku, T. W.; Lago, M. A.; Nichols, A. J.; Romoff, T. T.; Shah, D. H.; Vasko, J. A.; Wong, A.S.; Yellin, T. O.; Yuan, C.-K.; Samanen, J. M. J. Med. Chem. 1994, 37, 769.
16. (a) Charon, M. H.; Poggi, A.; Donati, M. B.; Marguerie, G. In: Peptides: Chemistry, Structure and Biology, Proceedings of the Eleventh American Peptide Symposium, pp.82-83, Rivier, J. E.; Marshall, G. R., Eds; ESCOM: Leiden; 1990.
17. (b) Tjoeng, F. S.; Fok, K. F.; Zupec, M. E.; Garland, R. B.; Miyano, M.; Panzer-Knodle, S.; King, L. W.; Taite, B. B.; Nicholson, N. S.; Feigen, L. P.; Adams, S. P. In: Peptides: Chemistry and Biology, Proceeding of the Twelfth American Peptide Symposium; pp. 752-754, Smith, J. A.; Rivier, J. E., Eds; ESCOM: Leiden, 1992.
18. Hartman, G. D.; Egbertson, M. S.; Halczenko, W. Laswell, W. L.; Duggan, M. E.; Smith, R. L.; Naylor, A. M.; Manno, P. D.; Lynch, R. J.; Zhang, G.; Chang, C.; Gould, R. J. J. Med. Chem. 1992, 35, 4640.
19. While this work was in progress, two patents describing benzimidazole and benzoxazole series of compounds were published, although the very potent 2,3-diaminopropionic acid class of compounds (11a-11e) were not discovered: (a) Austel, V.; Pieper, H.; Himmelsbach, F.; Linz, G.; Muller, T.; Weisenberger, J.; Seewaldt-Becker, E. European Patent 531,883, March 17, 1993.
20. (b) Hartman, G. D.; Egbertson, M. S.; Halczenko, W.; Askew, B. World Patent 94/089962, April 28, 1994.
21. Tsao, P.; Bozarth, J.; Jackson, S.; Forsythe, M.; Flint, S.; Mousa, S. Thrombosis Res. 1995, 77, 543.